Are you above the legal age to view this content in your province/state?

Home / Tag Archives: FSD Pharma

Tag Archives: FSD Pharma

FSD PHARMA APPOINTS FORMER MEMBER OF U.S. CONGRESS TO ITS BOARD OF DIRECTORS, ANNOUNCES SHARE CONSOLIDATION

FSD PHARMA APPOINTS FORMER MEMBER OF U.S. CONGRESS TO ITS BOARD OF DIRECTORS, ANNOUNCES SHARE CONSOLIDATION

TORONTO, October 11, 2019 – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) today announced the appointment of former U.S. congressman Stephen Buyer to the Company’s Board of Directors. The Company also announced that it will complete a consolidation of its class A multiple voting …

Read More »

FSD PHARMA CLOSES FIRST TRANCHE OF PRIVATE PLACEMENT AT $4.58 MILLION, EXTENDS OFFERING

FSD PHARMA CLOSES FIRST TRANCHE OF PRIVATE PLACEMENT AT $4.58 MILLION, EXTENDS OFFERING

TORONTO, October 1, 2019 – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company“) is pleased to provide an update on its previously announced private placement of its class B subordinate voting shares (“Shares”) at a price of CAD$0.10 per Share (the “Private Placement”).  On September 30, 2019, …

Read More »

FSD Pharma extends private placement

FSD Pharma extends private placement

U.K., October 1, 2019 (PROACTIVE)- It said the first tranche raised gross proceeds of C$4,583,085 from investors, issuing an aggregate of 45,830,850 shares at a price of C$0.10 each. The group noted that net proceeds from the private placement will be used for the expansion of the company’s biosciences division. …

Read More »

FSD Pharma Talks About Their Expanding Revenue Potential

FSD Pharma Talks About Their Expanding Revenue Potential

Phoenix, Arizona–(Newsfile Corp. – September 12, 2019) – The Stock Day Podcast welcomed FSD Pharma (OTCQB: FSDDF) (“the Company”), a company focused on the research and development of novel cannabinoid-based treatments for several central nervous system disorders including chronic pain, fibromyalgia and irritable bowel syndrome, and on the development of …

Read More »

FSD Pharma announced the launch of its online ordering system

FSD Pharma announced the launch of its online ordering system

TORONTO (August 21, 2019) – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) today announced the launch of its online ordering system for the direct fulfillment of medicinal cannabis orders. Through its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”), clients with a prescription from a medical …

Read More »

FSD Pharma is transforming its sprawling facility in Ontario into the world’s largest hydroponic indoor cannabis production and processing facility

Pharma is transforming its sprawling facility in Ontario into the world’s largest hydroponic indoor cannabis production and processing facility

Canada, August 7, 2019 (PROACTIVE)- The firm has had a busy 2019, as it continues its rapid expansion at its facility, while also pushing forward its research and development platform. Completing expansion at its facility, headquartered at the former Kraft plant in Cobourg, Ontario with an aim to build the world’s …

Read More »

A pharmacist and drug formulation specialist has been hired to assist with our product applications to Health Canada

A pharmacist and drug formulation specialist has been hired to assist with our product applications to Health Canada

TORONTO, July 31, 2019 /CNW/ – Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the “Company” or “Canntab“), the leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blends, is pleased to provide an update on a number of significant developments, as well as a clear outline of what to expect in …

Read More »

Adam Friedman, MD, FAAD, Ken Mackie, MD and Sara Jane Ward, Ph.D. join high-profile FSD Scientific Advisory Team

Adam Friedman, MD, FAAD, Ken Mackie, MD and Sara Jane Ward, Ph.D. join high-profile FSD Scientific Advisory Team

Canada, July 30, 2019 (STOCKHOUSE)- Expands the Scientific Advisory Board by adding three additional prominent researchers in clinical applications of medicinal cannabis. Adam Friedman, MD, FAAD, Ken Mackie, MD and Sara Jane Ward, Ph.D. join high-profile FSD Scientific Advisory Team FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” …

Read More »

FSD Pharma is boosting its scientific advisory board with the appointment of four new medical professionals

FSD Pharma is boosting its scientific advisory board with the appointment of four new medical professionals

Canada, July 30, 2019 (PROACTIVEINVESTORS USA)- The new appointments come as the medical cannabis company advances its efforts to pursue development of CBD-based therapies to replace widely used opioid painkillers in treatment programs. Dr Kaiser was named one of the 50 most influential health executives in 2019 FSD Pharma Inc (CSE:HUGE) …

Read More »

Disclaimer

Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.


Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.


DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.


Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.


Investment Value Finders is intended for those 21+ years of age only!